Fulcrum Therapeutics Inc (NASDAQ:FULC)

4.94
Delayed Data
As of 4:00pm ET
 +0.07 / +1.44%
Today’s Change
3.21
Today|||52-Week Range
33.10
-72.07%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Fulcrum Therapeutics Inc have a median target of 27.00, with a high estimate of 43.00 and a low estimate of 7.00. The median estimate represents a +446.56% increase from the last price of 4.94.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Fulcrum Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.66
Sales
$3.0M
Reporting Date
Aug 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.23%
 
 
 
 
 
 
Growthannually -17.00%
 
 
 
 
 

Sales

Growthquarterly 14.36%
 
 
 
 
 
 
Growthannually -42.03%
 
 
 
 
 
Key to the earnings and sales forecast charts.